To Evaluate The Efficacy And Safety Of GW685698X Drug In Adolescent And Adult Subjects With Persistent Asthma

This study is designed to determine if the investigational drug is effective and safe in individuals with asthma.

Official Title

A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Study to Evaluate the Efficacy and Safety of GW685698X 200mcg Twice Daily, GW685698X 200mcg and 400mcg Once Daily in the Morning, and GW685698X 200mcg and 400mcg Once Daily in the Evening Compared With Placebo for 8 Weeks in Adolescent and Adult Subjects (12 Years of Age and Older) With Persistent Asthma.

Conditions

• Asthma

Study Type

Interventional

Study Design

Treatment, Randomized, Double-Blind, Placebo Control, Single Group Assignment, Safety/Efficacy Study

Further Details

• Primary Outcomes: The primary efficacy measure will be mean change from baseline at Week 8 (last assessment on treatment using last observation carried forward) in tough (AM or PM pre-dose and pre-rescue bronchodilator) forced expiratory volume in one second (FEV1)

Study Start

November 2006

Eligibility & Criteria

• Ages Eligible for Study: 12 Years and above
• Genders Eligible for Study: Both

Inclusion criteria:

• Asthma diagnosis per NIH 2002
• Severity of Disease (a best FEV1 of 50-80% of the predicted normal)
• Reversibility of Disease (demonstrated >= 12% and 200mL reversibility of FEV1)
• Concurrent anti-asthma therapy for at least 3 months prior to Visit 1

Exclusion criteria:

• History of Life-threatening asthma and other concurrent respiratory illness tobacco use
• systemic, oral, parenteral, or depot corticosteroid use
• severe milk protein allergy
• positive oropharyngeal examination
  

  Total Enrolment

  648

  Contact Details

  • GSK Clinical Trials Call Center, Nedlands, 6009, Australia GSK Clinical Trials Call Center 1 877 379 3718
  • GSK Clinical Trials Call Center, Geelong, 3220, Australia GSK Clinical Trials Call Center 1 877 379 3718
  • GSK Clinical Trials Call Center, Concord, 2139, Australia GSK Clinical Trials Call Center 1 877 379 3718
  • GSK Clinical Trials Call Center, Toorak Gardens, 5065, Australia GSK Clinical Trials Call Center 1 877 379 3718
  • GSK Clinical Trials Call Center, Camperdown, 2050, Australia GSK Clinical Trials Call Center 1 877 379 3718
  • GSK Clinical Trials Call Center, Clayton, 3168, Australia GSK Clinical Trials Call Center 1 877 379 3718
  • GSK Clinical Trials Call Center, Adelaide, 5000, Australia GSK Clinical Trials Call Center 1 877 379 3718

  All content and media on the HealthEngine Blog is created and published online for informational purposes only. It is not intended to be a substitute for professional medical advice and should not be relied on as health or personal advice. Always seek the guidance of your doctor or other qualified health professional with any questions you may have regarding your health or a medical condition. Never disregard the advice of a medical professional, or delay in seeking it because of something you have read on this Website. If you think you may have a medical emergency, call your doctor, go to the nearest hospital emergency department, or call the emergency services immediately.